D-Tryptophan

D-Tryptophan

SCHEMBL3423849

CCC[C@H](N)C(=O)O.N[C@H](Cc1c[nH]c2ccccc12)C(=O)O

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.82
▸ MAPT P10636 3/20 0.82
▸ KMT2A Q03164 3/20 0.82
▸ LMNA P02545 2/20 0.82
▸ TSHR P16473 2/20 0.82
▸ BLM P54132 2/20 0.82
▸ PMP22 Q01453 2/20 0.82
▸ MEN1 O00255 2/20 0.82
▸ MPO P05164 1/20 0.82
▸ HIF1A Q16665 1/20 0.82
▸ APAF1 O14727 1/20 0.61
▸ POLB P06746 1/20 0.61
▸ RECQL P46063 1/20 0.61
▸ L3MBTL1 Q9Y468 1/20 0.61
▸ SMN1; SMN2 Q16637 1/20 0.59
▸ HTR2A P28223 3/20 0.57
▸ HTR1A P08908 2/20 0.57
▸ HTR2C P28335 2/20 0.57
▸ SLC6A4 P31645 2/20 0.57
▸ HTR7 P34969 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dl-Tryptophan SCHEMBL27562072 0.91 KDM4E (0.89) KDM4EMAPTKMT2ALMNATSHR
Tryptophan SCHEMBL30045975 0.91 KDM4E (0.89) KDM4EMAPTKMT2ALMNATSHR
Tryptophan SCHEMBL27798727 0.91 KDM4E (0.89) KDM4EMAPTKMT2ALMNATSHR
Tryptophan SCHEMBL27748748 0.91 KDM4E (0.94) KDM4EMAPTKMT2ALMNATSHR
Dl-Tryptophan SCHEMBL27748750 0.91 KDM4E (0.94) KDM4EMAPTKMT2ALMNATSHR
Dl-Tryptophan SCHEMBL28580277 0.91 KDM4E (0.94) KDM4EMAPTKMT2ALMNATSHR
Tryptophan SCHEMBL23141133 0.91 KMT2A (1.00) KDM4EMAPTKMT2ALMNATSHR
Dl-Tryptophan SCHEMBL4732052 0.91 KMT2A (1.00) KDM4EMAPTKMT2ALMNATSHR
Dl-Tryptophan SCHEMBL19161120 0.91 KMT2A (1.00) KDM4EMAPTKMT2ALMNATSHR
Dl-Tryptophan SCHEMBL7327 0.91 KMT2A (1.00) KDM4EMAPTKMT2ALMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3740496-A1 PROTEINACEOUS MOLECULES AND USES THEREFOR Epiaxis Therapeutics Pty Ltd (AU) 2020-11-25 — — EP disclosed
EP-3687561-A1 \"IMMUNOREGULATORY MOLECULES AND USES THEREFOR\ The Australian National University (AU) 2020-08-05 — — EP disclosed
EP-3472192-A1 SPIDER VENOM PEPTIDES AND METHODS OF USE FOR MODULATING SODIUM CHANNELS. The University of Queensland (AU) 2019-04-24 — — EP disclosed
WO-2019040994-A1 \"IMMUNOREGULATORY MOLECULES AND USES THEREFOR\ THE AUSTRALIAN NATIONAL UNIVERSITY (AU) 2019-03-07 — — WO disclosed
EP-3411061-A1 PROTEINACEOUS COMPOUNDS AND USES THEREFOR University of Canberra (AU) 2018-12-12 — — EP disclosed
EP-3387007-A1 PROTEINACEOUS MOLECULES AND METHODS OF USE The University of Queensland (AU) 2018-10-17 — — EP disclosed
WO-2017219081-A1 SPIDER VENOM PEPTIDES AND METHODS OF USE FOR MODULATING SODIUM CHANNELS. THE UNIVERSITY OF QUEENSLAND (AU) 2017-12-28 — — WO disclosed
WO-2017132728-A1 PROTEINACEOUS COMPOUNDS AND USES THEREFOR UNIVERSITY OF CANBERRA (AU) 2017-08-10 — — WO disclosed
WO-2017096431-A1 PROTEINACEOUS MOLECULES AND METHODS OF USE THE UNIVERSITY OF QUEENSLAND (AU) 2017-06-15 — — WO disclosed
EP-2922862-A1 COMPLEX-FORMATION-MODULATING AGENTS AND USES THEREFOR Queensland University Of Technology (AU) 2015-09-30 — — EP disclosed
EP-1285004-A1 SYNTHETIC PEPTIDES AND USES THEREFORE THE AUSTRALIAN NATIONAL UNIVERSITY (AU) 2003-02-26 — — EP disclosed
EP-1222255-A1 POLYPEPTIDE FRAGMENTS COMPRISING C-TERMINAL PORTION OF HELICOBACTER CATALASE CSL LIMITED (AU) 2002-07-17 — — EP disclosed
WO-2001098487-A1 POLYNUCLEOTIDES AND POLYPEPTIDES LINKED TO BLOOD PRESSURE REGULATION AND/OR FATIGUE THE UNIVERSITY OF QUEENSLAND (AU) 2001-12-27 — — WO disclosed
WO-2001090197-A1 SYNTHETIC PEPTIDES AND USES THEREFORE THE AUSTRALIAN NATIONAL UNIVERSITY (AU) 2001-11-29 — — WO disclosed
EP-1045859-A4 NOVEL SURFACE PROTEIN OF $i(NEISSERIA MENINGITIDIS) UNIV QUEENSLAND (AU) 2001-08-22 — — EP disclosed
WO-2001029198-A1 POLYPEPTIDE FRAGMENTS COMPRISING C-TERMINAL PORTION OF HELICOBACTER CATALASE CSL LIMITED (AU) 2001-04-26 — — WO disclosed
EP-1078003-A1 PLASMIN INHIBITORS FROM THE AUSTRALIAN BROWN SNAKE $i(PSEUDONAJA TEXTILIS TEXTILIS) THE UNIVERSITY OF QUEENSLAND (AU) 2001-02-28 — — EP disclosed
EP-1045859-A1 NOVEL SURFACE PROTEIN OF $i(NEISSERIA MENINGITIDIS) THE UNIVERSITY OF QUEENSLAND (AU) 2000-10-25 — — EP disclosed
WO-1999058569-A1 PLASMIN INHIBITORS FROM THE AUSTRALIAN BROWN SNAKE $i(PSEUDONAJA TEXTILIS TEXTILIS) THE UNIVERSITY OF QUEENSLAND (AU) 1999-11-18 — — WO disclosed
WO-1999031132-A1 NOVEL SURFACE PROTEIN OF $i(NEISSERIA MENINGITIDIS) THE UNIVERSITY OF QUEENSLAND (AU) 1999-06-24 — — WO disclosed
Send feedback